Europe's Alternative Protein Funding Up 56%

European alternative protein startups secured €236 million in private investment during the first half of 2026, a 56% increase over the same period in 2025. The analysis from the Good Food Institute Europe, using Net Zero Insights data, shows this is the highest half-yearly total since early 2024. This growth comes after a year of significant decline for the sector.

Fermentation companies drove the rebound, capturing 84% of all funding. The number of deals, however, halved, indicating a trend of larger investments concentrated on fewer companies. Europe maintained its position as the global leader for alternative protein investment, attracting over three-quarters of the world's total capital for the sector. Global investment, however, fell by 10% to €306 million.

Fermentation Funding Surges Ahead

Investment in fermentation startups has already exceeded their total for all of 2025. The sector is split into two main technological approaches: precision fermentation and biomass fermentation.

These figures were bolstered by several major deals. French precision fermentation company Standing Ovation secured €30 million. Verley, another French precision fermentation firm, raised €25 million as part of a larger round. Dutch biomass fermentation company The Protein Brewery attracted €18 million in a Series B extension.

Beyond private capital, fermentation firms also collected €67 million in grants during the first half of 2026. This marks a significant jump from the €45 million in grants raised by the entire alternative protein sector in the same period last year. Some projects combined funding sources. Solar Foods obtained a €78 million package from Business Finland for a factory. The European Innovation Council provided €12.5 million to Dutch startup Vivici. A consortium led by Adamo Foods secured a €10 million EU grant for a mycelium steak.

Plant-Based Segment Struggles

While fermentation thrived, the plant-based segment saw funding plummet. Investment dropped from €61 million in the first half of 2025 to just €18 million in the first half of 2026. Helene Grosshans, senior infrastructure investment manager at GFI Europe, explained the shift. "In this constrained investment climate, some plant-based companies are consolidating," she said. Others are seeking capital to scale from pilot plants to industrial production.

The cultivated meat sector in Europe showed modest positive signs, attracting €18 million in H1 2026. This figure is already close to the €20 million raised in all of 2025. Key deals included UK startup Meatly raising €12 million and Germany's Innocent Meat securing €6 million. Grosshans noted investment remains below its 2023 peak, highlighting a need for diversified funding to reach commercialisation.

The Push for Blended Finance

Experts argue that traditional venture capital models are ill-suited for the capital-intensive scale-up phase of food technology. GFI Europe convened over 40 investors to discuss new funding mechanisms. The discussions revealed that agrifood innovation does not fit the mould of rapid growth and returns expected in other tech sectors.

The proposed solution is blended finance. This approach mixes grants, loans, and equity to spread risk across a wider set of investors. Strategic use of public money could boost private investor confidence. Grosshans warned of the stakes. "With so much at stake for food security, climate goals and public health, we cannot leave protein diversification to the whims of the market," she stated. She pointed to Europe's fermentation companies as evidence that blended, risk-shared financing can work. The challenge is expanding that model to build a more resilient food system across all alternative protein types.